tiprankstipranks
Trending News
More News >
Hyfusin Group Holdings Ltd. (HK:8512)
:8512
Hong Kong Market

Hyfusin Group Holdings Ltd. (8512) AI Stock Analysis

Compare
3 Followers

Top Page

HK

Hyfusin Group Holdings Ltd.

(8512)

Rating:74Outperform
Price Target:
Hyfusin Group Holdings Ltd. shows robust financial performance with strong revenue growth and profitability. The company operates with low leverage, indicating solid financial health. However, challenges in cash flow generation need addressing. The technical indicators suggest a bearish trend, but valuation metrics indicate the stock is significantly undervalued, offering potential for upside. Overall, the stock is solid but requires close monitoring of cash flow stability.

Hyfusin Group Holdings Ltd. (8512) vs. iShares MSCI Hong Kong ETF (EWH)

Hyfusin Group Holdings Ltd. Business Overview & Revenue Model

Company DescriptionHyfusin Group Holdings Ltd. (8512) is a company engaged in the manufacturing and sale of candles and home fragrance products. The company operates in the consumer goods sector, offering a variety of scented candles, home fragrances, and related accessories. Hyfusin Group Holdings Ltd. serves a diverse customer base, including retailers and distributors, across various regions.
How the Company Makes MoneyHyfusin Group Holdings Ltd. generates revenue primarily through the production and sale of its candle and home fragrance products. The company's key revenue streams include wholesale distribution to retailers, direct sales to consumers through various channels, and private label manufacturing for other brands. Strategic partnerships with retailers and effective supply chain management play a significant role in optimizing the company's earnings. Additionally, Hyfusin Group Holdings Ltd. may engage in marketing and promotional activities to boost sales and expand its market presence.

Hyfusin Group Holdings Ltd. Financial Statement Overview

Summary
Hyfusin Group Holdings Ltd. demonstrates strong revenue and profit growth, supported by efficient operations and effective capital management. The balance sheet is robust with low leverage, while cash flow stability presents a challenge, requiring attention to ensure continued financial health. Overall, the company shows a solid financial performance with opportunities to enhance cash flow management.
Income Statement
85
Very Positive
Hyfusin Group Holdings Ltd. has shown consistent growth in revenue, with a solid revenue growth rate of 5% from 2023 to 2024. The Gross Profit Margin is robust at 38.7% in 2024, reflecting efficient cost management. Net Profit Margin improved significantly to 18.9% in 2024, indicating enhanced profitability. EBIT and EBITDA margins also demonstrate strong profitability levels, at 18.1% and 18.3% respectively. The company shows strong top-line growth and improving profitability.
Balance Sheet
78
Positive
The balance sheet of Hyfusin Group Holdings Ltd. indicates a healthy financial position, with a low Debt-to-Equity Ratio of 0.03 in 2024, suggesting minimal leverage and financial risk. Return on Equity is strong at 26.5%, highlighting effective use of equity capital. The Equity Ratio is high at 81.2%, underscoring a solid capital structure with substantial equity financing.
Cash Flow
70
Positive
Cash flow analysis shows challenges in operating cash flow generation in 2024, as it stands at zero, contrasting with strong operating cash flows in previous years. The Free Cash Flow Growth Rate is not calculable for 2024 due to zero values. Despite these issues, the Free Cash Flow to Net Income Ratio was strong in prior periods, but stability in cash flow generation needs improvement.
Breakdown
Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income StatementTotal Revenue
909.45M866.25M684.95M815.14M555.91M
Gross Profit
351.90M335.54M207.69M269.92M206.60M
EBIT
164.72M138.63M97.94M138.16M116.10M
EBITDA
166.54M154.19M109.20M144.93M122.68M
Net Income Common Stockholders
171.43M102.29M73.06M106.21M90.48M
Balance SheetCash, Cash Equivalents and Short-Term Investments
324.51M336.77M171.35M138.35M108.39M
Total Assets
796.79M686.92M501.32M482.98M353.74M
Total Debt
16.43M18.36M53.96M65.94M32.13M
Net Debt
-308.09M-318.41M-117.40M-72.41M-76.25M
Total Liabilities
149.81M181.35M98.06M152.53M129.48M
Stockholders Equity
646.97M505.57M403.26M330.46M224.26M
Cash FlowFree Cash Flow
0.00213.65M59.28M19.21M103.75M
Operating Cash Flow
0.00248.56M96.61M73.30M111.75M
Investing Cash Flow
0.00-31.15M-39.03M-60.12M-9.27M
Financing Cash Flow
0.00-51.99M-24.57M16.24M-24.13M

Hyfusin Group Holdings Ltd. Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.29
Price Trends
50DMA
0.30
Negative
100DMA
0.30
Negative
200DMA
0.29
Positive
Market Momentum
MACD
>-0.01
Positive
RSI
41.48
Neutral
STOCH
55.56
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:8512, the sentiment is Negative. The current price of 0.29 is below the 20-day moving average (MA) of 0.30, below the 50-day MA of 0.30, and above the 200-day MA of 0.29, indicating a neutral trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 41.48 is Neutral, neither overbought nor oversold. The STOCH value of 55.56 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:8512.

Hyfusin Group Holdings Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (66)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
81
Outperform
$273.21B16.2828.11%2.55%11.51%47.88%
80
Outperform
$1.39T40.7014.98%38.46%72.44%
75
Outperform
$129.09B18.2320.60%2.88%14.60%24.66%
75
Outperform
$41.01B12.5211.92%3.94%1.85%-6.19%
74
Outperform
HK$266.36M1.6629.75%4.99%88.39%
66
Neutral
$4.51B12.295.40%3.67%4.15%-12.21%
66
Neutral
$85.31B44.966.14%1.22%7.63%-24.23%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:8512
Hyfusin Group Holdings Ltd.
0.29
-0.03
-9.38%
HK:1177
Sino Biopharmaceutical
4.77
2.06
75.82%
HK:1913
Prada SpA
50.65
-9.31
-15.53%
HK:1810
Xiaomi
54.10
36.96
215.64%
HK:2020
ANTA Sports Products
97.25
17.40
21.79%
HK:2331
Li Ning Company
16.00
-2.38
-12.96%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.